Alkeon Capital Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,245,412
| Closed | -$214M | – | 198 |
|
|
2021
Q3 | $214M | Sell |
1,245,412
-2,719
| -0.2% | -$356K | 0.72% | 67 |
|
|
2021
Q2 | $157M | Sell |
1,248,131
-473,600
| -28% | -$59.7M | 0.56% | 81 |
|
|
2021
Q1 | $233M | Buy |
1,721,731
+3,310
| +0.2% | +$428K | 0.89% | 61 |
|
|
2020
Q4 | $220M | Buy |
1,718,421
+92,815
| +6% | +$10.9M | 0.83% | 56 |
|
|
2020
Q3 | $183M | Buy |
1,625,606
+125,000
| +8% | +$12.4M | 0.85% | 54 |
|
|
2020
Q2 | $143M | Buy |
1,500,606
+122,656
| +9% | +$11.8M | 0.76% | 55 |
|
|
2020
Q1 | $124M | Buy |
1,377,950
+800,000
| +138% | +$62.2M | 1.01% | 50 |
|
|
2019
Q4 | $30.6M | Sell |
577,950
-366,000
| -39% | -$16.7M | 0.29% | 96 |
|
|
2019
Q3 | $37.3M | Hold |
943,950
| – | – | 0.35% | 93 |
|
|
2019
Q2 | $38.8M | Buy |
943,950
+100,000
| +12% | +$4.14M | 0.38% | 94 |
|
|
2019
Q1 | $39.3M | Buy |
843,950
+470,000
| +126% | +$20.6M | 0.43% | 93 |
|
|
2018
Q4 | $16.3M | Buy |
373,950
+101,621
| +37% | +$5.08M | 0.23% | 104 |
|
|
2018
Q3 | $15.6M | Buy |
+272,329
| New | +$13.4M | 0.18% | 101 |
|